WO2014115768A1 - Liquid nutrition composition - Google Patents
Liquid nutrition composition Download PDFInfo
- Publication number
- WO2014115768A1 WO2014115768A1 PCT/JP2014/051265 JP2014051265W WO2014115768A1 WO 2014115768 A1 WO2014115768 A1 WO 2014115768A1 JP 2014051265 W JP2014051265 W JP 2014051265W WO 2014115768 A1 WO2014115768 A1 WO 2014115768A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- protein
- vitamin
- kcal
- casein
- composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 101
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 75
- 239000007788 liquid Substances 0.000 title claims abstract description 60
- 230000035764 nutrition Effects 0.000 title claims abstract description 14
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 44
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 44
- 235000018102 proteins Nutrition 0.000 claims abstract description 43
- 239000011575 calcium Substances 0.000 claims abstract description 42
- 102000014171 Milk Proteins Human genes 0.000 claims abstract description 35
- 108010011756 Milk Proteins Proteins 0.000 claims abstract description 35
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims abstract description 35
- 239000005018 casein Substances 0.000 claims abstract description 34
- 235000021240 caseins Nutrition 0.000 claims abstract description 34
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 34
- 239000011707 mineral Substances 0.000 claims abstract description 34
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 31
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 31
- 150000002632 lipids Chemical class 0.000 claims abstract description 30
- 239000011777 magnesium Substances 0.000 claims abstract description 28
- 229940088594 vitamin Drugs 0.000 claims abstract description 28
- 229930003231 vitamin Natural products 0.000 claims abstract description 28
- 235000013343 vitamin Nutrition 0.000 claims abstract description 28
- 239000011782 vitamin Substances 0.000 claims abstract description 28
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims abstract description 24
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 24
- 229910052749 magnesium Inorganic materials 0.000 claims abstract description 24
- 235000008939 whole milk Nutrition 0.000 claims abstract description 20
- 239000007857 degradation product Substances 0.000 claims abstract description 11
- 230000017854 proteolysis Effects 0.000 claims abstract description 10
- 108010064851 Plant Proteins Proteins 0.000 claims abstract description 5
- 235000021120 animal protein Nutrition 0.000 claims abstract description 5
- 235000021118 plant-derived protein Nutrition 0.000 claims abstract description 5
- 235000010755 mineral Nutrition 0.000 claims description 32
- 235000014633 carbohydrates Nutrition 0.000 claims description 23
- 235000021239 milk protein Nutrition 0.000 claims description 18
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 10
- 239000012141 concentrate Substances 0.000 claims description 10
- 239000011574 phosphorus Substances 0.000 claims description 10
- 229910052698 phosphorus Inorganic materials 0.000 claims description 10
- 150000003722 vitamin derivatives Chemical class 0.000 abstract description 12
- 102000011632 Caseins Human genes 0.000 description 32
- 108010076119 Caseins Proteins 0.000 description 32
- 230000000052 comparative effect Effects 0.000 description 18
- 235000018823 dietary intake Nutrition 0.000 description 16
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 12
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 10
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 8
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 8
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 8
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 8
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 6
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 6
- 229930003427 Vitamin E Natural products 0.000 description 6
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 6
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 6
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 6
- 235000019155 vitamin A Nutrition 0.000 description 6
- 239000011719 vitamin A Substances 0.000 description 6
- 235000019165 vitamin E Nutrition 0.000 description 6
- 229940046009 vitamin E Drugs 0.000 description 6
- 239000011709 vitamin E Substances 0.000 description 6
- 229940045997 vitamin a Drugs 0.000 description 6
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 5
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 5
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 5
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 5
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 5
- 229930003268 Vitamin C Natural products 0.000 description 5
- 229960000304 folic acid Drugs 0.000 description 5
- 235000019152 folic acid Nutrition 0.000 description 5
- 239000011724 folic acid Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000011669 selenium Substances 0.000 description 5
- 229910052711 selenium Inorganic materials 0.000 description 5
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 5
- 235000019154 vitamin C Nutrition 0.000 description 5
- 239000011718 vitamin C Substances 0.000 description 5
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 4
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 4
- 239000004375 Dextrin Substances 0.000 description 4
- 229920001353 Dextrin Polymers 0.000 description 4
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 4
- 229930003316 Vitamin D Natural products 0.000 description 4
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 230000002776 aggregation Effects 0.000 description 4
- 238000004220 aggregation Methods 0.000 description 4
- 229960002685 biotin Drugs 0.000 description 4
- 235000020958 biotin Nutrition 0.000 description 4
- 239000011616 biotin Substances 0.000 description 4
- 229910052804 chromium Inorganic materials 0.000 description 4
- 239000011651 chromium Substances 0.000 description 4
- 229910052802 copper Inorganic materials 0.000 description 4
- 239000010949 copper Substances 0.000 description 4
- 235000019425 dextrin Nutrition 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- 229910052750 molybdenum Inorganic materials 0.000 description 4
- 239000011733 molybdenum Substances 0.000 description 4
- 229960003966 nicotinamide Drugs 0.000 description 4
- 235000005152 nicotinamide Nutrition 0.000 description 4
- 239000011570 nicotinamide Substances 0.000 description 4
- 229940055726 pantothenic acid Drugs 0.000 description 4
- 235000019161 pantothenic acid Nutrition 0.000 description 4
- 239000011713 pantothenic acid Substances 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 235000019166 vitamin D Nutrition 0.000 description 4
- 239000011710 vitamin D Substances 0.000 description 4
- 150000003710 vitamin D derivatives Chemical class 0.000 description 4
- 229940046008 vitamin d Drugs 0.000 description 4
- 239000011701 zinc Substances 0.000 description 4
- 229910052725 zinc Inorganic materials 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 3
- 235000005687 corn oil Nutrition 0.000 description 3
- 239000002285 corn oil Substances 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 229960003512 nicotinic acid Drugs 0.000 description 3
- 235000001968 nicotinic acid Nutrition 0.000 description 3
- 239000011664 nicotinic acid Substances 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 235000020183 skimmed milk Nutrition 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 229940080237 sodium caseinate Drugs 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229930003448 Vitamin K Natural products 0.000 description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 238000012812 general test Methods 0.000 description 2
- XMBWDFGMSWQBCA-AKLPVKDBSA-N iodane Chemical compound [130IH] XMBWDFGMSWQBCA-AKLPVKDBSA-N 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 229910052748 manganese Inorganic materials 0.000 description 2
- 239000011572 manganese Substances 0.000 description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000003531 protein hydrolysate Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 230000009469 supplementation Effects 0.000 description 2
- 235000019168 vitamin K Nutrition 0.000 description 2
- 239000011712 vitamin K Substances 0.000 description 2
- 150000003721 vitamin K derivatives Chemical class 0.000 description 2
- 229940046010 vitamin k Drugs 0.000 description 2
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000037182 bone density Effects 0.000 description 1
- 239000000828 canola oil Substances 0.000 description 1
- 235000019519 canola oil Nutrition 0.000 description 1
- 229940071162 caseinate Drugs 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- NPFOYSMITVOQOS-UHFFFAOYSA-K iron(III) citrate Chemical compound [Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NPFOYSMITVOQOS-UHFFFAOYSA-K 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 229960004232 linoleic acid Drugs 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
- A23L2/66—Proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
Definitions
- the present invention relates to a liquid nutritional composition, and more particularly to a high concentration liquid nutritional composition administered orally or by tube.
- Nutrition is a particularly important issue for patients before and after surgery, as well as for elderly people who are difficult to eat a normal diet and those who need care, to live a healthy life.
- This nutritional management is performed by administration of the nutritional composition, and the nutritional composition is adjusted so as to contain nutritional components such as proteins, lipids, carbohydrates, vitamins, and minerals in a well-balanced manner (see, for example, Patent Document 1). ).
- a nutritional composition is calorie adjusted in order to maintain energy balance.
- examples of the administration form include oral administration and tube administration such as nasal and gastrostomy.
- the calorie adjustment of the nutritional composition can generally be adjusted to a high calorie content by adjusting the content of lipids, proteins and carbohydrates.
- a composition with an energy value of 1.0 kcal / mL has been the mainstream, but recently, various nutritional compositions with a composition with an energy value of about 1.5 kcal / mL have been proposed.
- the nutritional composition In the administration of the nutritional composition, long-term administration is very painful for the recipient, and the nutritional composition with a high energy value can reduce the dose and reduce the burden on the recipient. Efficient nutritional supplementation is possible.
- Lipids are useful for increasing the calorie per mL without increasing the solids concentration compared to proteins and carbohydrates.
- the “Japanese dietary intake standards [2010 version] formulated by the Ministry of Health, Labor and Welfare (May 29, 2009) the balance of protein, lipid and carbohydrate may be lost.
- a liquid nutritional composition having an energy of about 900 kcal to 1000 kcal per day is used. If this energy value is a normal nutritional composition of 900 kcal to 1000 kcal, the content of vitamins, minerals, etc. will not reach the standard amount / recommended amount of Japanese dietary intake standards [2010 version]. Need to be prepared. If one product is filled with minerals such as magnesium and calcium, the viscosity of the product may be high, the throat is worse in oral administration, the tube fluidity is worse in tube administration, and both administrations As a result, the administration time tends to increase. Moreover, when the amount of magnesium or calcium is excessive, it may bind to the protein and aggregate and precipitate in the nutritional composition.
- the object of the present invention is to suppress an increase in viscosity even when a high-concentration preparation is prepared so that the necessary intake of vitamins and minerals can be taken, and to improve fluidity of tubes in oral administration and tube fluidity in tube administration. Is to provide a liquid nutritional composition with high calories.
- the liquid nutritional composition of the present invention uses whole milk protein and casein as proteins, and the mass of total milk protein in the protein is set to be larger than the mass of casein. For example, if the amount of energy is less than 30%, specifically 29% or less, and minerals such as magnesium and calcium are increased, the increase in viscosity can be suppressed. Therefore, a high concentration and good energy balance can be obtained, and a liquid nutritional composition containing vitamins and minerals in excess of the standard and recommended amounts of the Japanese dietary intake standard [2010 version] when 900 kcal is ingested. In addition, since the liquid nutritional composition of the present invention has an energy value adjusted to 1.5 kcal / mL or more, the amount of intake can be reduced and the administration time can be shortened, thereby reducing the burden on the recipient. be able to.
- liquid nutrition composition of this invention can mix
- a liquid state means the state which has fluidity
- the liquid nutritional composition of the present invention contains protein, lipid, carbohydrate, vitamin and mineral, 1) energy value is 1.5 kcal / mL or more, 2) the protein is composed of whole milk protein and casein, animal 3) In the protein, the total milk protein mass is larger than the casein mass, and 4) the energy ratio of lipids in the composition is 29% or less. And 5) contains at least magnesium and calcium as minerals.
- Whole milk protein includes whole milk itself, whole milk concentrate, protein prepared from whole milk, skim milk, skim milk concentrate, milk protein concentrate, skim milk powder obtained by removing lactose, total milk protein, etc. Among them, it is preferable to use a milk protein concentrate.
- casein include acid casein such as lactic casein, casein hydrochloride, casein sulfate, or a mixture thereof separated from milk by a conventional method; caseinate composed of a casein salt such as casein sodium.
- animal protein degradation products and plant protein degradation products are not included.
- Animal proteolysates and plant proteolysates are produced by degrading proteins with acids and enzymes, and are used in nutritional compositions because of their good dispersibility. Since ingestion may be difficult, these animal protein degradation products and plant protein degradation products are not used in the present invention.
- the whole milk protein is contained in the protein more than casein.
- calcium can be blended in a form bound to protein, and high concentrations of magnesium and calcium can be contained by binding free magnesium and calcium with casein.
- the ratio of the casein to the total milk protein is preferably a protein mass ratio of 1: 1.1 to 1:13, more preferably 1: 1.1 to 1: 4.28. 1: 1.1 to 1: 2.72 is more preferable. It is preferable that the total milk protein is greater than casein since the viscosity suppressing effect of the liquid nutritional composition can be sufficiently obtained. Further, it is preferable that the total milk protein is 13 mass times or less of casein because an increase in the viscosity of the liquid nutritional composition can be suppressed.
- the protein content in the liquid nutritional composition is preferably 8 to 30% in terms of energy ratio, and more preferably 13 to 19%. If the protein content is outside the range of 8-30% in terms of energy ratio, the nutritional balance of the PFC ratio of the dietary intake standard of the Ministry of Health, Labor and Welfare may be deteriorated, so 8-30% is preferable.
- the energy ratio is calculated as 4 kcal / g.
- the lipid used in the present invention is not particularly limited as long as it can generally be administered orally or by tube.
- vegetable oils such as soybean oil, sesame oil, perilla oil, sunflower oil, safflower oil, algae oil, canola oil, palm oil, corn oil, corn oil, coconut oil, olive oil, rice oil; fish oil, beef fat, etc.
- MCT neutral fat, medium chain length fatty acid
- highly unsaturated fatty acids such as eicosapentaenoic acid, docosahexaenoic acid, linolenic acid, linoleic acid; and the like.
- One lipid may be used alone, or two or more lipids may be mixed and used. From the viewpoint of satisfying essential fatty acids, it is preferable to use a combination of a plurality of types of lipids.
- the lipid content in the liquid nutritional composition is 29% or less in terms of energy ratio, and preferably 20 to 29%. It is preferable that the lipid content is 29% or less in terms of energy ratio because the nutritional balance of the PFC ratio is improved.
- the energy ratio is calculated as 9 kcal / g.
- the carbohydrate used in the present invention is not particularly limited as long as it can generally be administered orally or by tube.
- starch, dextrin, lactose, sucrose, glucose, fructose, maltose and the like can be mentioned.
- the carbohydrate one kind may be used alone, or two or more kinds may be mixed and used. Among these, dextrin is preferable from the viewpoint of the effect of the present invention.
- the carbohydrate content in the liquid nutritional composition is determined by the amount of protein and lipid blended, and the amount varies as appropriate, but is preferably 50 to 69% in terms of energy ratio.
- a carbohydrate content of 50% or more in terms of energy ratio is preferable because it can be easily adjusted to a low-viscosity and high-calorie preparation, and a content of 69% or less is preferable because the nutritional balance of the PFC ratio improves.
- the energy ratio is calculated as 4 kcal / g.
- Vitamins used in the present invention include vitamin A, vitamin D, vitamin E, vitamin K, vitamin B 1 , vitamin B 2 , niacin, vitamin B 6 , vitamin B 12 , folic acid, pantothenic acid, biotin and vitamin C. It is sufficient that at least one of these vitamins is included, and it is preferable to include all of these vitamins. Further, examples of the mineral include calcium, magnesium, phosphorus, iron, zinc, copper, manganese, iodine, selenium, chromium and molybdenum, and at least magnesium and calcium are preferably included. . These vitamins and minerals are appropriately formulated so as to conform to “Japanese dietary intake standards [2010 edition]” (May 29, 2009) formulated by the Ministry of Health, Labor and Welfare.
- magnesium can be added at 296 mg / 900 kcal or more, preferably 310 mg / 900 kcal or more, more preferably 370 mg / 900 kcal or more.
- magnesium is blended in an amount of 310 mg / 900 kcal or more, the estimated average required amount of the dietary intake standard is satisfied, and when it is blended so as to be 370 mg / 900 kcal or more, the recommended amount of the dietary intake standard can be satisfied.
- Calcium can be added in a range of 650 mg / 900 kcal or more, preferably 650 to 2300 mg / 900 kcal, more preferably 800 to 1150 mg / 900 kcal.
- 650 mg / 900 kcal or more it is preferable to satisfy the estimated average required amount of the dietary intake standard, and when it is formulated so as to be 800 mg / 900 kcal or more, the recommended amount of the dietary intake standard can be satisfied.
- the recommended amount of calcium is taken when ingesting 900 kcal, and even if it is ingested 1800 kcal, there is a margin up to the tolerable upper limit, and it is possible to ingest other foods.
- the content of other vitamins and minerals should satisfy the recommended intake amount or the reference amount described in the dietary intake standards of the Ministry of Health, Labor and Welfare.
- the recommended intake / reference amount of each component is as follows: vitamin A 850-2700 ⁇ g RE, vitamin D 5.5-50 ⁇ g, vitamin E 7.0-650 mg, vitamin K75 ⁇ g or more, vitamin B 1 1.4 mg or more, vitamin B 2 1.6 mg or more, niacin (nicotinamide) 15 to 250 mg, vitamin B 6 1.4 to 40 mg, vitamin B 12 2.4 ⁇ g or more, folic acid 240 to 1300 ⁇ g Pantothenic acid 6 mg or more, biotin 50 ⁇ g or more, vitamin C 100 mg or more, phosphorus 1000 to 3000 mg, iron 11.0 to 40 mg, zinc 12 to 30 mg, manganese 4.0 to 11 mg, copper 0.9 to 10 mg, iodine 130 to 2200 ⁇ g, Selenium 30-210
- the concentration of sodium the minimum required amount in terms of salt is 1.5 g, and when it is high blood pressure and there is salt restriction, it is less than 6 g. It is preferable to set so as to become (hypertension treatment guideline 2009 edition).
- the mass ratio of calcium to phosphorus is preferably 0.74 or more. If Ca / P is 0.74 or more, bone density is significantly higher than when less than 0.74 is blended (Japanese dietary intake standard [2010 edition], P202).
- liquid nutrition composition of this invention may be added, such as emulsifier, a phosphate, and a citrate.
- the liquid nutritional composition of the present invention has an energy value of 1.5 kcal / mL or more, preferably 1.5 to 2.0 kcal / mL, more preferably 1.5 to 1.75 kcal / mL.
- the energy value can be adjusted within the range of the energy ratio of the various components described above.
- the liquid nutritional composition of the present invention requires water in addition to the above components such as proteins, lipids, carbohydrates, vitamins and minerals.
- a fluid nutritional composition can be obtained by mixing water and these components.
- the mixing ratio of water and the component to be mixed in the water is not particularly limited, and at the time of ingestion of 900 kcal, vitamins and minerals are included more than the standard amount / recommended amount of the Japanese dietary intake standard [2010 version] What is necessary is just to make it the viscosity in 20 degreeC become 50 mPa * s or less when preparing so that an energy value may be 1.5 kcal / mL or more.
- the liquid nutrition composition of the present invention can be prepared, for example, as follows. (1) Add an appropriate amount of water to proteins, carbohydrates, and minerals, mix them to make a liquid, and add lipids and, if necessary, emulsifiers to the liquids and mix to prepare the liquid nutritional composition of the present invention. . (2) An appropriate amount of protein, carbohydrate and mineral is added to water to prepare the liquid nutritional composition of the present invention.
- the mixing method and mixing order of each component are arbitrary and are not specifically limited.
- the liquid nutritional composition of the present invention thus prepared has no aggregation or precipitation, and the viscosity at 20 ° C. is adjusted to 50 mPa ⁇ s or less, preferably 8 to 30 mPa ⁇ s. Therefore, the throat over oral administration is improved, the tube fluidity in tube administration is improved, and the administration time can be reduced.
- the viscosity as used in the field of this invention means the value measured by the method prescribed
- the liquid nutritional composition of the present invention is usually provided by heat sterilization.
- the heat sterilization method may follow a conventional method and is not particularly limited.
- the well-known soft synthetic resin, the laminated body of paper and metal foil, etc. are mentioned.
- Example 1 Using 5 L of warm water of 40-60 ° C., 567 g of milk protein concentrate (protein content 80%) as total milk protein, 40 g of sodium caseinate (protein content 90%) as casein, 420 g as lipid, 2330 g dextrin as carbohydrate, vitamin And a mineral and vitamin mixture having the following composition as minerals, so that the mass ratio of milk protein concentrate and casein sodium is the value shown in Table 1, and the energy ratio is the value shown in Table 1, and The magnesium (Mg) amount and the calcium (Ca) amount were sequentially added so as to have the values shown in Table 1, and mixed using a TK homomixer. Finally, warm water (40-60 ° C.) was added to adjust to 10 L.
- the amounts and the Ca / P ratio are shown in Table 1.
- the liquid nutritional composition of Example 1 was a composition with the characteristics that it was easy to drink without aggregation or precipitation when visually confirmed.
- Examples 2 to 21 The mass ratio of whole milk protein and casein is the value shown in Table 1, and the energy ratio of protein, lipid and carbohydrate is the value shown in Table 1, and the amount of magnesium (Mg) and calcium ( The same as Example 1 except that the compounding amount of each component was changed so that the amount of Ca) was the value described in Table 1, and further the Ca / P ratio was the value described in Table 1.
- phosphorus is 999 mg
- selenium is 50.04 ⁇ g
- vitamin D is 15 ⁇ g
- vitamin E is 2.24 mg
- vitamin E is 1.503 mg
- vitamin Each component was blended such that C was 200 mg and vitamin B 12 was 4.5 ⁇ g in Example 21.
- the liquid nutritional compositions of Examples 2 to 21 were compositions that were easy to drink and did not aggregate or precipitate when visually confirmed.
- Comparative Examples 1 and 2 The mass ratio of whole milk protein and casein is the value shown in Table 1, and the energy ratio of protein, lipid and carbohydrate is the value shown in Table 1, and the amount of magnesium (Mg) and calcium ( The same as Example 1 except that the compounding amount of each component was changed so that the amount of Ca) was the value described in Table 1, and further the Ca / P ratio was the value described in Table 1. Prepared.
- the liquid nutritional compositions of Comparative Examples 1 and 2 were compositions that were high in viscosity and difficult to drink.
- the emulsion was homogenized using a high-pressure homogenizer by repeating the two-stage treatment of 5 MPa for the first stage and 50 MPa for the second stage five times.
- Vitamin A and Mineral Mixtures Vitamin A 250,000 IU, Vitamin B 1 150 mg, Vitamin B 2 220 mg, Vitamin B 6 370 mg, Vitamin B 12 120 mg, Vitamin D 3 20,000 IU, Vitamin E 7500 IU, Vitamin C 10 g, Nicotinamide 2000 mg, Pantothene A mixture of calcium acid 1000 mg, folic acid 3000 mg, sodium chloride 77 g, potassium chloride 150 g, magnesium carbonate 158 g, and iron citrate 14 g was used.
- the liquid nutritional composition of Comparative Example 3 had a low viscosity and was easy to drink.
- Comparative Example 4 Comparative Example 3 was prepared in the same manner as Comparative Example 3 except that the calcium per 900 kcal was 800 mg and magnesium was 370 mg.
- the liquid nutritional composition of Comparative Example 4 was a composition in which a large amount of aggregates were generated and could not be homogenized.
- Comparative Example 5 Comparative Example 3 was prepared in the same manner as Comparative Example 3 except that a milk protein concentrate was used as the whole milk protein and casein calcium (1800 g as the protein) was used as the casein.
- the liquid nutrient composition of Comparative Example 5 was a composition aggregated in a gel-like or pudding-like form.
- Comparative Example 6 Comparative Example 5 was prepared in the same manner as Comparative Example 5 except that the calcium per 900 kcal was 800 mg and magnesium was 370 mg.
- the liquid nutritional composition of Comparative Example 6 was a composition aggregated in a gel-like or pudding-like form.
- liquid nutritional compositions were prepared using acid casein instead of sodium caseinate.
- the obtained liquid nutritional composition was a composition having the characteristics that it was easy to drink without aggregation or precipitation when visually confirmed.
- liquid nutritional composition that has a high concentration and a good energy balance, and that can ingest the necessary intake of vitamins and minerals.
- the liquid nutritional composition of the present invention is a high-concentration preparation containing the necessary intake of vitamins and minerals, and is a high-calorie preparation. Therefore, it is suitable for patients and elderly people who need nutritional supplementation by oral administration or tube administration. It can be effectively used in the field of nutritional compositions to be administered.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pediatric Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
1製品に、マグネシウムやカルシウムなどのミネラルを充足させようとすると、製剤的に粘度が高くなる場合があり、経口投与ではのど越しが悪くなり、経管投与ではチューブ流動性が悪化し、両投与経路とも結果的に投与時間が増加してしまう傾向がある。また、マグネシウムやカルシウムの量が過剰になると蛋白質と結合して、栄養組成物中で凝集、沈殿してしまう場合がある。 When managing tube feeding, for example, a liquid nutritional composition having an energy of about 900 kcal to 1000 kcal per day is used. If this energy value is a normal nutritional composition of 900 kcal to 1000 kcal, the content of vitamins, minerals, etc. will not reach the standard amount / recommended amount of Japanese dietary intake standards [2010 version]. Need to be prepared.
If one product is filled with minerals such as magnesium and calcium, the viscosity of the product may be high, the throat is worse in oral administration, the tube fluidity is worse in tube administration, and both administrations As a result, the administration time tends to increase. Moreover, when the amount of magnesium or calcium is excessive, it may bind to the protein and aggregate and precipitate in the nutritional composition.
〔1〕蛋白質、脂質、炭水化物、ビタミンおよびミネラルを含有し、次の1)~5)の特徴を有する液状栄養組成物。
1)組成物のエネルギー値が1.5kcal/mL以上である。
2)前記蛋白質が全乳蛋白およびカゼインからなり、動物性蛋白質分解物および植物性蛋白質分解物を含まない。
3)前記蛋白質中、前記全乳蛋白の質量が前記カゼインの質量よりも多い。
4)組成物中の前記脂質の含有量が、エネルギー比で29%以下である。
5)前記ミネラルとして、少なくともマグネシウムおよびカルシウムを含む。
〔2〕前記カゼインと前記全乳蛋白との比率が、蛋白質の質量比で1:1.1~1:13である、前記〔1〕に記載の液状栄養組成物。
〔3〕組成物のエネルギー900kcal当り、前記カルシウムを650mg以上および前記マグネシウムを296mg以上含む、前記〔1〕または〔2〕に記載の液状栄養組成物。
〔4〕前記全乳蛋白が、乳蛋白濃縮物である、前記〔1〕~〔3〕のいずれか1項に記載の液状栄養組成物。
〔5〕前記エネルギー値が、1.5~2.0kcal/mLである、前記〔1〕~〔4〕のいずれか1項に記載の液状栄養組成物。
〔6〕組成物中の前記蛋白質および前記炭水化物の含有量が、エネルギー比でそれぞれ、8~30%および50~69%である、前記〔1〕~〔5〕のいずれか1項に記載の液状栄養組成物。
〔7〕リンを含有し、カルシウムとリンとの質量比(Ca/P)が、0.74以上である、前記〔1〕~〔6〕のいずれか1項に記載の液状栄養組成物。 That is, the present invention is as follows.
[1] A liquid nutritional composition containing proteins, lipids, carbohydrates, vitamins and minerals and having the following characteristics 1) to 5).
1) The energy value of the composition is 1.5 kcal / mL or more.
2) The protein consists of whole milk protein and casein, and does not contain animal protein degradation products or plant protein degradation products.
3) In the protein, the mass of the whole milk protein is larger than the mass of the casein.
4) The content of the lipid in the composition is 29% or less in terms of energy ratio.
5) As said mineral, at least magnesium and calcium are included.
[2] The liquid nutritional composition according to [1], wherein the ratio of the casein to the total milk protein is 1: 1.1 to 1:13 by mass ratio of the protein.
[3] The liquid nutritional composition according to [1] or [2] above, wherein the calcium is 650 mg or more and the magnesium is 296 mg or more per 900 kcal of the composition.
[4] The liquid nutritional composition according to any one of [1] to [3], wherein the whole milk protein is a milk protein concentrate.
[5] The liquid nutritional composition according to any one of [1] to [4], wherein the energy value is 1.5 to 2.0 kcal / mL.
[6] The content of the protein and the carbohydrate in the composition according to any one of the above [1] to [5], in which the energy ratio is 8 to 30% and 50 to 69%, respectively. Liquid nutrition composition.
[7] The liquid nutritional composition according to any one of [1] to [6] above, which contains phosphorus and has a mass ratio (Ca / P) of calcium to phosphorus of 0.74 or more.
カゼインとしては、常法により牛乳から分離された乳酸カゼイン、塩酸カゼイン、硫酸カゼインまたはこれらの混合物等の酸カゼイン;カゼインナトリウム等のカゼイン塩からなるカゼイネート等が挙げられる。 Whole milk protein includes whole milk itself, whole milk concentrate, protein prepared from whole milk, skim milk, skim milk concentrate, milk protein concentrate, skim milk powder obtained by removing lactose, total milk protein, etc. Among them, it is preferable to use a milk protein concentrate.
Examples of casein include acid casein such as lactic casein, casein hydrochloride, casein sulfate, or a mixture thereof separated from milk by a conventional method; caseinate composed of a casein salt such as casein sodium.
これらのビタミンおよびミネラルは、厚生労働省策定の「日本人の食事摂取基準[2010年版]」(平成21年5月29日)に適合するように適宜配合される。 Vitamins used in the present invention include vitamin A, vitamin D, vitamin E, vitamin K, vitamin B 1 , vitamin B 2 , niacin, vitamin B 6 , vitamin B 12 , folic acid, pantothenic acid, biotin and vitamin C. It is sufficient that at least one of these vitamins is included, and it is preferable to include all of these vitamins. Further, examples of the mineral include calcium, magnesium, phosphorus, iron, zinc, copper, manganese, iodine, selenium, chromium and molybdenum, and at least magnesium and calcium are preferably included. .
These vitamins and minerals are appropriately formulated so as to conform to “Japanese dietary intake standards [2010 edition]” (May 29, 2009) formulated by the Ministry of Health, Labor and Welfare.
ナトリウムの濃度は、食塩換算で最低必要量が1.5gであり、高血圧で食塩制限がある場合6g未満であることから、想定最大摂取量の1800kcal摂取時でも食塩相当量にて最大5g以下となるように設定することが好ましい(高血圧治療ガイドライン2009年版)。 In addition, since there is a possibility that the blood concentration tends to increase, it is preferable from the viewpoint of safety that potassium is lower than the dietary intake standard (JJPEN. Vol. 19 No. 6, 1997, p567-633). .
As for the concentration of sodium, the minimum required amount in terms of salt is 1.5 g, and when it is high blood pressure and there is salt restriction, it is less than 6 g. It is preferable to set so as to become (hypertension treatment guideline 2009 edition).
本発明において、水と該水に混合させる成分との混合比は特に限定されず、900kcal摂取時に、ビタミン、ミネラルが日本人の食事摂取基準[2010年版]の目安量・推奨量以上含まれ、エネルギー値が1.5kcal/mL以上となるよう調製した際に、20℃における粘度が、50mPa・s以下となるようにすればよい。 The liquid nutritional composition of the present invention requires water in addition to the above components such as proteins, lipids, carbohydrates, vitamins and minerals. A fluid nutritional composition can be obtained by mixing water and these components.
In the present invention, the mixing ratio of water and the component to be mixed in the water is not particularly limited, and at the time of ingestion of 900 kcal, vitamins and minerals are included more than the standard amount / recommended amount of the Japanese dietary intake standard [2010 version] What is necessary is just to make it the viscosity in 20 degreeC become 50 mPa * s or less when preparing so that an energy value may be 1.5 kcal / mL or more.
(1)蛋白質、炭水化物、ミネラルに適量の水を添加し、混合し、液状物とし、この液状物に脂質、必要に応じて乳化剤を添加し混合し、本発明の液状栄養組成物を調製する。
(2)水に蛋白質、炭水化物、ミネラルを適量添加し、本発明の液状栄養組成物を調製する。
なお、各成分の混合方法及び混合順序は任意であり、特に限定されない。 The liquid nutrition composition of the present invention can be prepared, for example, as follows.
(1) Add an appropriate amount of water to proteins, carbohydrates, and minerals, mix them to make a liquid, and add lipids and, if necessary, emulsifiers to the liquids and mix to prepare the liquid nutritional composition of the present invention. .
(2) An appropriate amount of protein, carbohydrate and mineral is added to water to prepare the liquid nutritional composition of the present invention.
In addition, the mixing method and mixing order of each component are arbitrary and are not specifically limited.
5Lの40~60℃の温水を使用し、全乳蛋白として乳蛋白濃縮物(蛋白質含量80%)567g、カゼインとしてカゼインナトリウム(蛋白質含量90%)40g、脂質として420g、炭水化物としてデキストリン2330g、ビタミンおよびミネラルとして下記組成のビタミン及びミネラル混合物を、乳蛋白濃縮物およびカゼインナトリウムの質量比が表1に記載の値となるように、かつエネルギー比が表1に記載の値となるように、なおかつマグネシウム(Mg)量およびカルシウム(Ca)量が表1に記載の値となるように、順次添加して、TKホモミキサーを用いて混合した。最後に温水(40~60℃)を加え10Lに調整した。
ビタミン及びミネラル混合物は、900kcal当り、ビタミンA850μgRE、ビタミンB11.4mg、ビタミンB21.6mg、ビタミンB61.4mg、ビタミンB122.4μg、ビタミンD5.5μg、ビタミンE7.0mg、ビタミンC100mg、ニコチン酸アミド15.0mg、パントテン酸6.0mg、葉酸240μg、ビタミンK75μg、ビオチン50.0μg、カルシウム800mg、マグネシウム370mg、リン1081mg、鉄11.0mg、亜鉛12.0mg、銅0.9mg、マンガン4.0mg、ヨウ素130μg、セレン30.0μg、クロム40.0μg、モリブデン30.0μg、の混合物を用いた。 (Example 1)
Using 5 L of warm water of 40-60 ° C., 567 g of milk protein concentrate (protein content 80%) as total milk protein, 40 g of sodium caseinate (protein content 90%) as casein, 420 g as lipid, 2330 g dextrin as carbohydrate, vitamin And a mineral and vitamin mixture having the following composition as minerals, so that the mass ratio of milk protein concentrate and casein sodium is the value shown in Table 1, and the energy ratio is the value shown in Table 1, and The magnesium (Mg) amount and the calcium (Ca) amount were sequentially added so as to have the values shown in Table 1, and mixed using a TK homomixer. Finally, warm water (40-60 ° C.) was added to adjust to 10 L.
Vitamin A and mineral mineral mixture per 900 kcal, vitamin A 850 μg RE, vitamin B 1 1.4 mg, vitamin B 2 1.6 mg, vitamin B 6 1.4 mg, vitamin B 12 2.4 μg, vitamin D 5.5 μg, vitamin E 7.0 mg, Vitamin C 100 mg, nicotinamide 15.0 mg, pantothenic acid 6.0 mg, folic acid 240 μg, vitamin K 75 μg, biotin 50.0 μg, calcium 800 mg, magnesium 370 mg, phosphorus 1081 mg, iron 11.0 mg, zinc 12.0 mg, copper 0.9 mg , Manganese 4.0 mg, iodine 130 μg, selenium 30.0 μg, chromium 40.0 μg, molybdenum 30.0 μg.
実施例1の液状栄養組成物は、目視にて確認したところ凝集や沈殿はなく、飲みやすい特長のある組成物であった。 Energy value of the prepared liquid nutritional composition, total milk protein (as protein mass) and casein ratio (as protein mass), total protein, lipid and carbohydrate energy ratio, magnesium (Mg) content and calcium (Ca) The amounts and the Ca / P ratio are shown in Table 1.
The liquid nutritional composition of Example 1 was a composition with the characteristics that it was easy to drink without aggregation or precipitation when visually confirmed.
全乳蛋白とカゼインの質量比が表1に記載の値となるように、かつ蛋白質、脂質および炭水化物のエネルギー比が表1に記載の値となるように、なおかつマグネシウム(Mg)量およびカルシウム(Ca)量が表1に記載の値となるように、さらにはCa/P比が表1に記載の値となるように、各成分の配合量を変更したこと以外は、実施例1と同様に調製した。なお、実施例18~21ではリンを999mg、セレンを50.04μg、ビタミンDを15μgに、実施例18ではビタミンEを2.24mgに、実施例19~21ではビタミンEを1.503mg、ビタミンCを200mgに、実施例21ではビタミンB12を4.5μgとなるように各成分を配合した。
実施例2~21の液状栄養組成物は、目視にて確認したところ凝集や沈殿はなく、飲みやすい特長のある組成物であった。 (Examples 2 to 21)
The mass ratio of whole milk protein and casein is the value shown in Table 1, and the energy ratio of protein, lipid and carbohydrate is the value shown in Table 1, and the amount of magnesium (Mg) and calcium ( The same as Example 1 except that the compounding amount of each component was changed so that the amount of Ca) was the value described in Table 1, and further the Ca / P ratio was the value described in Table 1. Prepared. In Examples 18 to 21, phosphorus is 999 mg, selenium is 50.04 μg, vitamin D is 15 μg, in Example 18, vitamin E is 2.24 mg, in Examples 19 to 21, vitamin E is 1.503 mg, vitamin Each component was blended such that C was 200 mg and vitamin B 12 was 4.5 μg in Example 21.
The liquid nutritional compositions of Examples 2 to 21 were compositions that were easy to drink and did not aggregate or precipitate when visually confirmed.
全乳蛋白とカゼインの質量比が表1に記載の値となるように、かつ蛋白質、脂質および炭水化物のエネルギー比が表1に記載の値となるように、なおかつマグネシウム(Mg)量およびカルシウム(Ca)量が表1に記載の値となるように、さらにはCa/P比が表1に記載の値となるように、各成分の配合量を変更したこと以外は、実施例1と同様に調製した。
比較例1、2の液状栄養組成物は、粘度が高く飲みにくい組成物であった。 (Comparative Examples 1 and 2)
The mass ratio of whole milk protein and casein is the value shown in Table 1, and the energy ratio of protein, lipid and carbohydrate is the value shown in Table 1, and the amount of magnesium (Mg) and calcium ( The same as Example 1 except that the compounding amount of each component was changed so that the amount of Ca) was the value described in Table 1, and further the Ca / P ratio was the value described in Table 1. Prepared.
The liquid nutritional compositions of Comparative Examples 1 and 2 were compositions that were high in viscosity and difficult to drink.
70.90Lの温水(60℃)に、乳蛋白濃縮物を蛋白量として3600g、カゼインナトリウムを蛋白量として1800g、カゼイン分解物を蛋白量として1800g、乳化剤としてコハク酸モノグリセライド220g、炭水化物としてデキストリン26420gを添加し、TKホモミキサーを用いて混合した。
得られた液状物に、コーン油7090g、下記組成のビタミン及びミネラル混合物を添加し、TKホモミキサーを用いて予備乳化し、水を添加して総量を100Lに調整した。前記乳化物を高圧ホモジナイザーを用いて、一段目5MPa、二段目50MPaの2段階処理を5回反復して均質化した。
ビタミン及びミネラル混合物は、ビタミンA250,000IU、ビタミンB1150mg、ビタミンB2220mg、ビタミンB6370mg、ビタミンB12120mg、ビタミンD320,000IU、ビタミンE7500IU、ビタミンC10g、ニコチン酸アミド2000mg、パントテン酸カルシウム1000mg、葉酸3000mg、塩化ナトリウム77g、塩化カリウム150g、炭酸マグネシウム158g、クエン酸鉄14gの混合物を用いた。
比較例3の液状栄養組成物は、粘度が低く飲みやすい組成物であった。 (Comparative Example 3)
In 70.90 L of warm water (60 ° C.), 3600 g of milk protein concentrate as protein amount, 1800 g of sodium caseinate as protein amount, 1800 g as casein degradation product as protein amount, 220 g of succinic acid monoglyceride as emulsifier, and 26420 g of dextrin as carbohydrate Add and mix using TK homomixer.
To the obtained liquid, 7090 g of corn oil and a vitamin and mineral mixture having the following composition were added, pre-emulsified using a TK homomixer, and water was added to adjust the total amount to 100 L. The emulsion was homogenized using a high-pressure homogenizer by repeating the two-stage treatment of 5 MPa for the first stage and 50 MPa for the second stage five times.
Vitamin A and Mineral Mixtures: Vitamin A 250,000 IU, Vitamin B 1 150 mg, Vitamin B 2 220 mg, Vitamin B 6 370 mg, Vitamin B 12 120 mg, Vitamin D 3 20,000 IU, Vitamin E 7500 IU, Vitamin C 10 g, Nicotinamide 2000 mg, Pantothene A mixture of calcium acid 1000 mg, folic acid 3000 mg, sodium chloride 77 g, potassium chloride 150 g, magnesium carbonate 158 g, and iron citrate 14 g was used.
The liquid nutritional composition of Comparative Example 3 had a low viscosity and was easy to drink.
比較例3において、900kcal当たりのカルシウムを800mg、マグネシウムを370mgとした以外は比較例3と同様に調製した。
比較例4の液状栄養組成物は、凝集物が大量に発生し均質化できない組成物であった。 (Comparative Example 4)
Comparative Example 3 was prepared in the same manner as Comparative Example 3 except that the calcium per 900 kcal was 800 mg and magnesium was 370 mg.
The liquid nutritional composition of Comparative Example 4 was a composition in which a large amount of aggregates were generated and could not be homogenized.
比較例3において、全乳蛋白として乳蛋白濃縮物を用い、カゼインとしてカゼインカルシウム(蛋白質として1800g)を用いた以外は比較例3と同様に調製した。
比較例5の液状栄養組成物は、ゲル状・プリン状に凝集した組成物であった。 (Comparative Example 5)
Comparative Example 3 was prepared in the same manner as Comparative Example 3 except that a milk protein concentrate was used as the whole milk protein and casein calcium (1800 g as the protein) was used as the casein.
The liquid nutrient composition of Comparative Example 5 was a composition aggregated in a gel-like or pudding-like form.
比較例5において、900kcal当たりのカルシウムを800mg、マグネシウムを370mgとした以外は比較例5と同様に調製した。
比較例6の液状栄養組成物は、ゲル状・プリン状に凝集した組成物であった。 (Comparative Example 6)
Comparative Example 5 was prepared in the same manner as Comparative Example 5 except that the calcium per 900 kcal was 800 mg and magnesium was 370 mg.
The liquid nutritional composition of Comparative Example 6 was a composition aggregated in a gel-like or pudding-like form.
上記調製された実施例1~17および比較例1~3、5、6の液状栄養組成物を20℃で10分間保存後、20mLを採取して単一円筒形回転粘度計(ビスメトロン粘度計VDA2型、芝浦セムテック株式会社製)を用いて、測定した(第十六改正 日本薬局方一般試験法 <2.53> 粘度測定法)。
測定された粘度に基づき、下記評価基準により評価した。結果を表1にあわせて示す。
〔評価基準〕
A: 30mPa・s以下
B: 30mPa・sを超え、50mPa・s以下
C: 50mPa・sを超え、100mPa・s以下
D: 100mPa・sを超える <Evaluation of viscosity>
After the liquid nutritional compositions prepared in Examples 1 to 17 and Comparative Examples 1 to 3, 5, and 6 prepared above were stored at 20 ° C. for 10 minutes, 20 mL was collected and a single cylindrical rotational viscometer (Bismetron viscometer VDA2 (Sixteenth revision Japanese Pharmacopoeia General Test Method <2.53> Viscosity Measurement Method).
Based on the measured viscosity, the following evaluation criteria were used. The results are shown in Table 1.
〔Evaluation criteria〕
A: 30 mPa · s or less B: Over 30 mPa · s, 50 mPa · s or less C: Over 50 mPa · s, 100 mPa · s or less D: Over 100 mPa · s
Claims (7)
- 蛋白質、脂質、炭水化物、ビタミンおよびミネラルを含有し、次の1)~5)の特徴を有する液状栄養組成物。
1)組成物のエネルギー値が1.5kcal/mL以上である。
2)前記蛋白質が全乳蛋白およびカゼインからなり、動物性蛋白質分解物および植物性蛋白質分解物を含まない。
3)前記蛋白質中、前記全乳蛋白の質量が前記カゼインの質量よりも多い。
4)組成物中の前記脂質の含有量が、エネルギー比で29%以下である。
5)前記ミネラルとして、少なくともマグネシウムおよびカルシウムを含む。 A liquid nutritional composition containing proteins, lipids, carbohydrates, vitamins and minerals and having the following characteristics 1) to 5).
1) The energy value of the composition is 1.5 kcal / mL or more.
2) The protein consists of whole milk protein and casein, and does not contain animal protein degradation products or plant protein degradation products.
3) In the protein, the mass of the whole milk protein is larger than the mass of the casein.
4) The content of the lipid in the composition is 29% or less in terms of energy ratio.
5) As said mineral, at least magnesium and calcium are included. - 前記カゼインと前記全乳蛋白との比率が、蛋白質の質量比で1:1.1~1:13である、請求項1に記載の液状栄養組成物。 The liquid nutritional composition according to claim 1, wherein the ratio of the casein to the whole milk protein is 1: 1.1 to 1:13 in terms of a mass ratio of the protein.
- 900kcal当り、前記カルシウムを650mg以上および前記マグネシウムを296mg以上含む、請求項1または請求項2に記載の液状栄養組成物。 The liquid nutrition composition according to claim 1 or 2, comprising 650 mg or more of calcium and 296 mg or more of magnesium per 900 kcal.
- 前記全乳蛋白が、乳蛋白濃縮物である、請求項1~請求項3のいずれか1項に記載の液状栄養組成物。 The liquid nutrition composition according to any one of claims 1 to 3, wherein the whole milk protein is a milk protein concentrate.
- 前記エネルギー値が、1.5~2.0kcal/mLである、請求項1~請求項4のいずれか1項に記載の液状栄養組成物。 The liquid nutrition composition according to any one of claims 1 to 4, wherein the energy value is 1.5 to 2.0 kcal / mL.
- 組成物中の前記蛋白質および前記炭水化物の含有量が、エネルギー比でそれぞれ、8~30%および50~69%である、請求項1~請求項5のいずれか1項に記載の液状栄養組成物。 The liquid nutrition composition according to any one of claims 1 to 5, wherein the content of the protein and the carbohydrate in the composition is 8 to 30% and 50 to 69% in energy ratio, respectively. .
- リンを含有し、カルシウムとリンとの質量比(Ca/P)が、0.74以上である、請求項1~請求項6のいずれか1項に記載の液状栄養組成物。 The liquid nutrition composition according to any one of claims 1 to 6, comprising phosphorus, wherein a mass ratio of calcium to phosphorus (Ca / P) is 0.74 or more.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020157019698A KR102069931B1 (en) | 2013-01-23 | 2014-01-22 | Liquid Nutrition Composition |
CN201480005880.XA CN104981172B (en) | 2013-01-23 | 2014-01-22 | Liquid alimentation composition |
JP2014553571A JP5788112B2 (en) | 2013-01-23 | 2014-01-22 | Liquid nutrition composition |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013010202 | 2013-01-23 | ||
JP2013-010202 | 2013-01-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2014115768A1 true WO2014115768A1 (en) | 2014-07-31 |
Family
ID=51227559
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2014/051265 WO2014115768A1 (en) | 2013-01-23 | 2014-01-22 | Liquid nutrition composition |
Country Status (5)
Country | Link |
---|---|
JP (1) | JP5788112B2 (en) |
KR (1) | KR102069931B1 (en) |
CN (1) | CN104981172B (en) |
TW (1) | TWI580362B (en) |
WO (1) | WO2014115768A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2016165240A (en) * | 2015-03-09 | 2016-09-15 | サントリー食品インターナショナル株式会社 | High energy beverage comprising insoluble calcium |
KR20230112745A (en) | 2021-01-28 | 2023-07-27 | 이엔 오츠카 세이야쿠가부시키가이샤 | gel nutritional composition |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG11201811779UA (en) * | 2016-08-08 | 2019-02-27 | Meiji Co Ltd | Acidic liquid nutritional composition |
JP2018184369A (en) * | 2017-04-26 | 2018-11-22 | 株式会社明治 | Intellectual work ability improvement composition and cognition ability improvement composition |
CN118678890A (en) * | 2022-03-31 | 2024-09-20 | 营养株式会社 | Liquid nutritional composition and package |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08196236A (en) * | 1995-01-19 | 1996-08-06 | Terumo Corp | Liquid nutritive diet and high-caloric nutrient |
JPH10210951A (en) * | 1997-01-28 | 1998-08-11 | Morinaga Milk Ind Co Ltd | Liquid liquid food and aseptic high calorie liquid food |
JPH119187A (en) * | 1997-06-26 | 1999-01-19 | Snow Brand Milk Prod Co Ltd | Nourishing beverage and its production |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4620819B2 (en) * | 1999-08-25 | 2011-01-26 | 味の素株式会社 | High calorie high protein liquid food |
JP4063022B2 (en) | 2002-09-11 | 2008-03-19 | 日油株式会社 | Liquid food and beverage composition and food and beverage |
-
2014
- 2014-01-22 KR KR1020157019698A patent/KR102069931B1/en active Active
- 2014-01-22 CN CN201480005880.XA patent/CN104981172B/en active Active
- 2014-01-22 JP JP2014553571A patent/JP5788112B2/en active Active
- 2014-01-22 WO PCT/JP2014/051265 patent/WO2014115768A1/en active Application Filing
- 2014-01-23 TW TW103102531A patent/TWI580362B/en active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08196236A (en) * | 1995-01-19 | 1996-08-06 | Terumo Corp | Liquid nutritive diet and high-caloric nutrient |
JPH10210951A (en) * | 1997-01-28 | 1998-08-11 | Morinaga Milk Ind Co Ltd | Liquid liquid food and aseptic high calorie liquid food |
JPH119187A (en) * | 1997-06-26 | 1999-01-19 | Snow Brand Milk Prod Co Ltd | Nourishing beverage and its production |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2016165240A (en) * | 2015-03-09 | 2016-09-15 | サントリー食品インターナショナル株式会社 | High energy beverage comprising insoluble calcium |
KR20230112745A (en) | 2021-01-28 | 2023-07-27 | 이엔 오츠카 세이야쿠가부시키가이샤 | gel nutritional composition |
CN116744973A (en) * | 2021-01-28 | 2023-09-12 | En大冢制药株式会社 | Gel-like nutritional composition |
KR102618203B1 (en) | 2021-01-28 | 2023-12-27 | 이엔 오츠카 세이야쿠가부시키가이샤 | Gel nutritional composition |
CN116744973B (en) * | 2021-01-28 | 2024-04-09 | En大冢制药株式会社 | Gel-like nutritional composition |
Also Published As
Publication number | Publication date |
---|---|
JPWO2014115768A1 (en) | 2017-01-26 |
TW201442643A (en) | 2014-11-16 |
CN104981172B (en) | 2017-09-05 |
JP5788112B2 (en) | 2015-09-30 |
KR102069931B1 (en) | 2020-01-23 |
KR20150110536A (en) | 2015-10-02 |
CN104981172A (en) | 2015-10-14 |
TWI580362B (en) | 2017-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5787480B2 (en) | Long-term enteral nutrition for maintenance | |
JP5892948B2 (en) | Nutritional emulsion containing calcium HMB | |
JP2009506012A (en) | Nutrients in obese patients | |
EP2819528B1 (en) | Energy-rich liquid nutritional composition having improved organoleptic properties | |
JP5788112B2 (en) | Liquid nutrition composition | |
JPS6236645B2 (en) | ||
KR20120104382A (en) | Liquid food composition | |
WO2009072869A1 (en) | High energy liquid enteral nutritional composition | |
JP5384333B2 (en) | Liquid nutritional composition containing whey protein at high concentration and method for producing the same | |
JPWO2014030605A1 (en) | Nutritional composition | |
EP2380582A1 (en) | Low-concentration nutritional composition | |
KR101397863B1 (en) | Liquid nutritional composition containing sodium at high concentration and method of producing the same | |
JP2000300194A (en) | Nourishing porridge | |
JP6439681B2 (en) | Semi-solid high nutrition food | |
JP2009159990A (en) | Highly nutritive food | |
JP2006022068A (en) | Serum lipid metabolism improver | |
JP6083962B2 (en) | Acid-resistant liquid nutritional composition | |
WO2019139032A1 (en) | Muscle loss inhibiting composition for cancer patients | |
JP7085704B1 (en) | Gel-like nutritional composition | |
TWI814232B (en) | gel nutritional composition | |
WO2023190295A1 (en) | Liquid nutritional composition and package | |
JP2017101002A (en) | Nutritional composition for improving ascites retention |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14742765 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2014553571 Country of ref document: JP Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 20157019698 Country of ref document: KR Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: IDP00201504508 Country of ref document: ID |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 14742765 Country of ref document: EP Kind code of ref document: A1 |